ALSO NOTED: GSK suing Abbott over HIV-drug price; Harvard genius joins MIT-Novartis effort;

> GlaxoSmithKline is joining a lawsuit against Abbott Laboratories over the jacked-up price of Norvir, and anti-HIV drug. Report

> A top Harvard chemist will join the MIT-Novartis Center for Continuous Manufacturing, a joint effort of the university and the Big Pharma company to develop new ways of making drugs. Report

> The FDA approved new labeling for the Bristol-Myers Squibb leukemia drug Sprycel; patients can now start on a lower dose of the drug, to help avert side effects. Report

> Indian pharma Wockhardt is considering a spin-off of its R&D operations, in the wake of similar moves by competitors. Report

> The FDA: Caught between a rock and a hard place. Report

And Finally... Athletes given placebo on competition day get a performance boost. Report

Suggested Articles

Mobile has become universal, accessible, and multi-generational. It’s time for life science brands to revolutionize how they’re telling their story.

Former Retrophin CEO was hoping for a SCOTUS hail mary to escape his seven-year fraud sentences Turns out the court was interest in hearing his plea.

A new investigation shines light on how Purdue pushed back on negative coverage of opioids, placed opioid-friendly experts in think tanks and more.